Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Jun;73(12):1466–1472. doi: 10.1038/bjc.1996.278

Different biodistribution of 99mTc-labelled chimeric mouse-human monoclonal antibody between athymic mice model and human.

N Oriuchi 1, N Watanabe 1, S Sugiyama 1, T Higuchi 1, K Imai 1, H Yamanaka 1, M Hashimoto 1, H Kanda 1, K Endo 1
PMCID: PMC2074533  PMID: 8664114

Abstract

Biodistribution of chimeric mouse/human monoclonal antibody against non-specific cross-reacting antigen (chNCA Ab) was studied in athymic mice and patients with metastatic bone disease. 99mTc-chNCA Ab showed a high labelling efficiency, stability and also a high binding ratio to human granulocytes. Since NCA showed cross-reactivity with carcinoembryonic antigen (CEA), animal experiments showed that 99mTc-chNCA Ab was accumulated in the xenografted tumour which expressed CEA, suggesting the preserved immunoreactivity of labelled materials. In the clinical study, injected 99mTc-chNCA Ab formed a high molecular weight complex immediately after intravenous administration and was trapped mainly in liver. The first-phase plasma half-life was 6.4 +/- 1.1 min. None of the patients showed adverse reaction or human antimurine or anti-chimeric antibody in their serum. 99mTc-chNCA Ab demonstrated remarkably different biodistribution between patients and the animal model and showed different pharmacokinetics from other murine and chimeric Abs reported previously. For safety HPLC analysis should be performed before clinical radioimmunodetection or radioimmunotherapy by incubating radiolabelled MAb with human serum under strict conditions.

Full text

PDF
1466

Images in this article

1468Figure 2
on p.1468
1469Figure 3
on p.1469
1469Figure 4
on p.1469

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum R. P., Hertel A., Lorenz M., Schwarz A., Encke A., Hör G. 99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results. Nucl Med Commun. 1989 May;10(5):345–352. doi: 10.1097/00006231-198905000-00005. [DOI] [PubMed] [Google Scholar]
  2. Bosslet K., Lüben G., Schwarz A., Hundt E., Harthus H. P., Seiler F. R., Muhrer C., Klöppel G., Kayser K., Sedlacek H. H. Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen (CEA). Int J Cancer. 1985 Jul 15;36(1):75–84. doi: 10.1002/ijc.2910360113. [DOI] [PubMed] [Google Scholar]
  3. Boulianne G. L., Hozumi N., Shulman M. J. Production of functional chimaeric mouse/human antibody. Nature. 1984 Dec 13;312(5995):643–646. doi: 10.1038/312643a0. [DOI] [PubMed] [Google Scholar]
  4. Davidson B. R., Babich J., Young H., Waddington W., Clarke G., Short M., Boulos P., Styles J., Dean C. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody. Br J Cancer. 1991 Nov;64(5):850–856. doi: 10.1038/bjc.1991.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dillman R. O., Beauregard J. C., Sobol R. E., Royston I., Bartholomew R. M., Hagan P. S., Halpern S. E. Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells. Cancer Res. 1984 May;44(5):2213–2218. [PubMed] [Google Scholar]
  6. Goldenberg D. M., DeLand F., Kim E., Bennett S., Primus F. J., van Nagell J. R., Jr, Estes N., DeSimone P., Rayburn P. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med. 1978 Jun 22;298(25):1384–1386. doi: 10.1056/NEJM197806222982503. [DOI] [PubMed] [Google Scholar]
  7. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  8. Hnatowich D. J., Gionet M., Rusckowski M., Siebecker D. A., Roche J., Shealy D., Mattis J. A., Wilson J., McGann J., Hunter R. E. Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibody. Cancer Res. 1987 Nov 15;47(22):6111–6117. [PubMed] [Google Scholar]
  9. Khazaeli M. B., Saleh M. N., Liu T. P., Meredith R. F., Wheeler R. H., Baker T. S., King D., Secher D., Allen L., Rogers K. Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans. Cancer Res. 1991 Oct 15;51(20):5461–5466. [PubMed] [Google Scholar]
  10. Koga H., Kanda H., Nakashima M., Watanabe Y., Endo K., Watanabe T. Mouse-human chimeric monoclonal antibody to carcinoembryonic antigen (CEA): in vitro and in vivo activities. Hybridoma. 1990 Feb;9(1):43–56. doi: 10.1089/hyb.1990.9.43. [DOI] [PubMed] [Google Scholar]
  11. Ledermann J. A., Marston N. J., Stahel R. A., Waibel R., Buscombe J. R., Ell P. J. Biodistribution and tumour localisation of 131I SWA11 recognising the cluster w4 antigen in patients with small cell lung cancer. Br J Cancer. 1993 Jul;68(1):119–121. doi: 10.1038/bjc.1993.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LoBuglio A. F., Wheeler R. H., Trang J., Haynes A., Rogers K., Harvey E. B., Sun L., Ghrayeb J., Khazaeli M. B. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4220–4224. doi: 10.1073/pnas.86.11.4220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Locher J. T., Seybold K., Andres R. Y., Schubiger P. A., Mach J. P., Buchegger F. Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal anti-granulocytes antibodies. Nucl Med Commun. 1986 Sep;7(9):659–670. [PubMed] [Google Scholar]
  14. Mach J. P., Carrel S., Forni M., Ritschard J., Donath A., Alberto P. Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation. N Engl J Med. 1980 Jul 3;303(1):5–10. doi: 10.1056/NEJM198007033030102. [DOI] [PubMed] [Google Scholar]
  15. Mather S. J., Ellison D. Reduction-mediated technetium-99m labeling of monoclonal antibodies. J Nucl Med. 1990 May;31(5):692–697. [PubMed] [Google Scholar]
  16. Meredith R. F., LoBuglio A. F., Plott W. E., Orr R. A., Brezovich I. A., Russell C. D., Harvey E. B., Yester M. V., Wagner A. J., Spencer S. A. Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibody. J Nucl Med. 1991 Jun;32(6):1162–1168. [PubMed] [Google Scholar]
  17. Munz D. L., Sandrock D., Rilinger N. Comparison of immunoscintigraphy and colloid scintigraphy of bone marrow. Lancet. 1990 Jul 28;336(8709):258–259. doi: 10.1016/0140-6736(90)91794-b. [DOI] [PubMed] [Google Scholar]
  18. Oriuchi N., Endo K., Watanabe N., Sugiyama S., Asao T., Takenoshita S., Nagamachi Y., Baum R. P. Semiquantitative SPECT tumor uptake of technetium-99m-labeled anti-CEA monoclonal antibody in colorectal tumor. J Nucl Med. 1995 Apr;36(4):679–683. [PubMed] [Google Scholar]
  19. Potter H., Weir L., Leder P. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci U S A. 1984 Nov;81(22):7161–7165. doi: 10.1073/pnas.81.22.7161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Primus F. J., Bennett S. J., Kim E. E., DeLand F. H., Zahn M. C., Goldenberg D. M. Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen. Cancer Res. 1980 Mar;40(3):497–501. [PubMed] [Google Scholar]
  21. Reuland P., Winker K. H., Heuchert T., Ruck P., Müller-Schauenburg W., Weller S., Feine U. Detection of infection in postoperative orthopedic patients with technetium-99m-labeled monoclonal antibodies against granulocytes. J Nucl Med. 1991 Dec;32(12):2209–2214. [PubMed] [Google Scholar]
  22. Sakahara H., Saga T., Endo K., Hattori N., Hosono M., Kobayashi H., Shirato M., Yamamuro T., Toyama S., Arano Y. In vivo instability of reduction-mediated 99mTc-labeled monoclonal antibody. Nucl Med Biol. 1993 Jul;20(5):617–623. doi: 10.1016/0969-8051(93)90030-x. [DOI] [PubMed] [Google Scholar]
  23. Schroff R. W., Foon K. A., Beatty S. M., Oldham R. K., Morgan A. C., Jr Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res. 1985 Feb;45(2):879–885. [PubMed] [Google Scholar]
  24. Shawler D. L., Bartholomew R. M., Smith L. M., Dillman R. O. Human immune response to multiple injections of murine monoclonal IgG. J Immunol. 1985 Aug;135(2):1530–1535. [PubMed] [Google Scholar]
  25. Watanabe N., Oriuchi N., Sugiyama S., Kuroki M., Matsuoka Y. Radioimmunoscintigraphy of colorectal cancer with technetium-99m-labeled murine anti-carcinoembryonic antigen monoclonal antibody in athymic nude mice. Ann Nucl Med. 1994 Feb;8(1):23–30. doi: 10.1007/BF03164983. [DOI] [PubMed] [Google Scholar]
  26. von Kleist S., Chavanel G., Burtin P. Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2492–2494. doi: 10.1073/pnas.69.9.2492. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES